Skip to content
NYSE: IGC | Borse Berlin: IGS1.BE | Frankfurt: IGS1
IGC

IGC

India Globalization Capital Inc.

  • Home
  • Hyalolex
  • Infrastructure Business
  • Investors
    • Press Releases
    • SEC Filings
    • XBRL Files
    • Leadership
    • Governance

IGC Filed a Patent for a New Formulation to Treat Pain

July 21, 2020 by Rachel
Posted in News and Filings, Press Releases

Post navigation

← IGC Receives a Notice of Allowance from the U.S. Patent Office

Site Map

  • Home
  • Hyalolex
  • Infrastructure Business
  • Investors
    • Press Releases
    • SEC Filings
    • XBRL Files
    • Leadership
    • Governance

Contact

India Globalization Capital
Potomac, MD, United States

info@igcinc.us
301-983-0998